- Home
- RSG vs GSK Comparison
RSG vs GSK Comparison
Compare RSG & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSG
- GSK
- Stock Information
- Founded
- RSG 1996
- GSK 1715
- Country
- RSG United States
- GSK United Kingdom
- Employees
- RSG N/A
- GSK N/A
- Industry
- RSG Environmental Services
- GSK Biotechnology: Pharmaceutical Preparations
- Sector
- RSG Utilities
- GSK Health Care
- Exchange
- RSG Nasdaq
- GSK Nasdaq
- Market Cap
- RSG 73.0B
- GSK 81.9B
- IPO Year
- RSG 1998
- GSK N/A
- Fundamental
- Price
- RSG $222.36
- GSK $43.45
- Analyst Decision
- RSG Buy
- GSK Hold
- Analyst Count
- RSG 22
- GSK 2
- Target Price
- RSG $257.52
- GSK N/A
- AVG Volume (30 Days)
- RSG 1.2M
- GSK 5.7M
- Earning Date
- RSG 10-30-2025
- GSK 10-29-2025
- Dividend Yield
- RSG 1.12%
- GSK 3.72%
- EPS Growth
- RSG 13.24
- GSK N/A
- EPS
- RSG 6.76
- GSK 1.13
- Revenue
- RSG $16,366,000,000.00
- GSK $43,336,073,439.00
- Revenue This Year
- RSG $5.28
- GSK $5.43
- Revenue Next Year
- RSG $5.43
- GSK $5.14
- P/E Ratio
- RSG $32.91
- GSK $38.43
- Revenue Growth
- RSG 5.13
- GSK 0.59
- 52 Week Low
- RSG $197.61
- GSK $31.72
- 52 Week High
- RSG $258.75
- GSK $45.59
- Technical
- Relative Strength Index (RSI)
- RSG 35.09
- GSK 61.93
- Support Level
- RSG $221.56
- GSK $43.04
- Resistance Level
- RSG $231.65
- GSK $45.59
- Average True Range (ATR)
- RSG 2.73
- GSK 0.81
- MACD
- RSG -0.26
- GSK 0.25
- Stochastic Oscillator
- RSG 11.12
- GSK 66.27
About RSG Republic Services Inc.
Republic Services is the second-largest integrated provider of traditional solid waste services in the United States, operating roughly 208 active landfills and 248 transfer stations. The company serves residential, commercial, and industrial end markets. It also runs sizable recycling and hazardous waste collection and disposal operations in North America.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.